Tienilic acid
From Wikipedia, the free encyclopedia
 |
|
|
Tienilic acid
|
|
| Systematic (IUPAC) name | |
| 2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid | |
| Identifiers | |
| CAS number | |
| ATC code | C03 |
| PubChem | |
| Chemical data | |
| Formula | C13H8Cl2O4S |
| Mol. mass | 331.17 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 95% |
| Metabolism | Hepatic |
| Half life | 6 hours |
| Excretion | Renal and biliary |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Withdrawn |
| Routes | Oral |
Tienilic acid (INN and BAN) or ticrynafen (USAN) is a diuretic drug with uric acid-lowering (uricosuric) action, formerly marketed for the treatment of hypertension. It was withdrawn in 1982, shortly after its introduction to the market, after case reports in the United States indicated a link between the use of ticrynafen and hepatitis.[1]
Tienilic acid was found to act as a suicide substrate at the cytochrome P450 enzymes involved in drug metabolism. Unfortunately, the metabolic reaction carried out by these enzymes converted tienilic acid to a thiophene sulfoxide which proved highly electrophilic. This encouraged a Michael reaction leading to alkylation of a thiol group in the enzyme's active site. Loss of water from the thiophene sulfoxide restored the thiophene ring and resulted in tienilic acid being covalently linked to the enzyme, thus inhibiting the enzyme irreversibly.
[edit] References
- ^ Manier JW, Chang WW, Kirchner JP, Beltaos E (1982). Hepatotoxicity associated with ticrynafen – a uricosuric diuretic. Am J Gastroenterol 77 (6), 401–4. PMID 7091125
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
